Programa de Pós-graduação em Tocoginecologia, Medical School of Botucatu, São Paulo State University (UNESP), Botucatu, Brazil.
Department of Medicine, Universidade Federal de São Carlos (UFSCAR), São Carlos, Brazil.
BJOG. 2020 Dec;127(13):1618-1626. doi: 10.1111/1471-0528.16470. Epub 2020 Sep 14.
To describe clinical characteristics of pregnant and postpartum women with severe COVID-19 in Brazil and to examine risk factors for mortality.
Cross-sectional study based on secondary surveillance database analysis.
Nationwide Brazil.
978 Brazilian pregnant and postpartum women notified as COVID-19 Acute Respiratory Distress Syndrome (ARDS) cases with complete outcome (death or cure) up to 18 June 2020.
Data was abstracted from the Brazilian ARDS Surveillance System (ARDS-SS) database. All eligible cases were included. Data on demographics, clinical characteristics, intensive care resources use and outcomes were collected. Risk factors for mortality were examined by multivariate logistic regression.
Case fatality rate.
We identified 124 maternal deaths, corresponding to a case fatality rate among COVID-19 ARDS cases in the obstetric population of 12.7%. At least one comorbidity was present in 48.4% of fatal cases compared with 24.9% in survival cases. Among women who died, 58.9% were admitted to ICU, 53.2% had invasive ventilation and 29.0% had no respiratory support. The multivariate logistic regression showed that the main risk factors for maternal death by COVID-19 were being postpartum at onset of ARDS, obesity, diabetes and cardiovascular disease, whereas white ethnicity had a protective effect.
Negative outcomes of COVID-19 in this population are affected by clinical characteristics but social determinants of health also seem to play a role. It is urgent to reinforce containment measures targeting the obstetric population and ensure high quality care throughout pregnancy and the postpartum period.
A total of 124 COVID-19 maternal deaths were identified in Brazil. Symptoms onset at postpartum and comorbidities are risk factors.
描述巴西重症 COVID-19 孕妇和产后妇女的临床特征,并探讨其死亡的危险因素。
基于二次监测数据库分析的横断面研究。
巴西全国。
截至 2020 年 6 月 18 日,巴西共有 978 例被通报为 COVID-19 急性呼吸窘迫综合征(ARDS)病例且结局完整(死亡或治愈)的孕妇和产后妇女。
数据来自巴西 ARDS 监测系统(ARDS-SS)数据库。纳入所有符合条件的病例。收集人口统计学、临床特征、重症监护资源使用和结局等数据。采用多变量逻辑回归分析死亡的危险因素。
病死率。
共发现 124 例孕产妇死亡,COVID-19 导致产科人群中 ARDS 病例的病死率为 12.7%。与存活病例相比,死亡病例至少有一种合并症的比例为 48.4%,而存活病例为 24.9%。在死亡的妇女中,58.9%入住 ICU,53.2%接受有创通气,29.0%无呼吸支持。多变量逻辑回归显示,COVID-19 导致孕产妇死亡的主要危险因素为 ARDS 发病时处于产后、肥胖、糖尿病和心血管疾病,而白种人具有保护作用。
该人群 COVID-19 的不良结局受临床特征影响,但健康的社会决定因素似乎也发挥了作用。迫切需要加强针对产科人群的遏制措施,并确保整个孕期和产后期间提供高质量的护理。
巴西共发现 124 例 COVID-19 孕产妇死亡。症状发病时处于产后和合并症是危险因素。